Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage ...

Nadir prostate specific antigen (PSA) levels and time to nadir PSA (TnPSA) following radiotherapy have been proposed as predictors of outcome in prostate cancer. Ray et al. attempted to determine ...

氘可来昔替尼治疗组患者的 ACR和 PASI应答率显著高于安慰剂组，且患者报告生活质量有更明显改善。 近日，百时美施贵宝公布了POETYK PsA-2（IM011-055 ...

It does not currenlty have a cure, but there are many treatment options. Psoriatic arthritis (PsA) is a painful type of arthritis that causes joint pain, swelling, and stiffness. If you have ...

Deucravacitinib (Sotyktu) demonstrated efficacy in treating patients with active psoriatic arthritis (PsA), achieving higher American College of Rheumatology (ACR) 20 response rates (ie ...

Psoriatic arthritis (PsA) is an immune-mediated condition, and people with PsA may be at a higher risk of developing many neurological conditions. Psoriatic arthritis (PsA) is an immune-mediated ...

In late 2024, Bristol Myers Squibb announced positive topline results from its pivotal Phase 3 trials, POETYK PsA-1 and PsA-2, evaluating Sotyktu ...